Ling Cheng

Risankizumab for Ulcerative Colitis

Edouard Louis, Stefan Schreiber, Remo Panaccione et al. · JAMA · 2024 · 110 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Efficacy and Safety of Upadacitinib or Elsubrutinib Alone or in Combination for Patients With Systemic Lupus Erythematosus: A Phase 2 Randomized Controlled Trial

Joan T. Merrill, Yoshiya Tanaka, David D’Cruz et al. · Arthritis & Rheumatology · 2024 · 53 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Pharmacokinetics of Risankizumab in Asian Healthy Subjects and Patients With Moderate to Severe Plaque Psoriasis, Generalized Pustular Psoriasis, and Erythrodermic Psoriasis

Amit Khatri, Doerthe Eckert, Rajneet K. Oberoi et al. · The Journal of Clinical Pharmacology · 2019 · 30 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Lack of Effect of 12-Week Treatment with Risankizumab on the Pharmacokinetics of Cytochrome P450 Probe Substrates in Patients with Moderate to Severe Chronic Plaque Psoriasis

Amit Khatri, Ling Cheng, Anne Camez et al. · Clinical Pharmacokinetics · 2018 · 28 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Factors Associated With Willingness to Try Different Pain Treatments for Pain After a Spinal Cord Injury

Jennifer A. Haythornthwaite, Stephen T. Wegener, Lisa M. Benrud‐Larson et al. · Clinical Journal of Pain · 2003 · 23 citations

Medicine, Physical Medicine, Rehabilitation Medicine +17